saving classname here bc not compiling for capitalize
Your browser is old and is not supported. Upgrade for better security.
Explore
Raise
Raise Funding
FAQ
Login
Signup
Invest in
Pace Diagnostics
Revolutionary point-of-care, affordable early detection Lung cancer and Tuberculosis diagnostics
$0
reserved of a $50,000 goal
INVEST
min $100
INVESTMENT TERMS
Terms will be decided later
Pitch Video
Investor Panel
pacediagnostics.com
Los Angeles CA
Technology
Female Founder
B2B
Retail
Minority Founder
Overview
Updates
15
What People Say
24
Ask a Question
7
Highlights
1
Raised $2.5 million in seed investment; Won > $6 million in grants from US DoD, NIH, and NSF
2
Huge markets and financial opportunities: 3.1 billion USD tuberculosis & 20 billion USD lung cancer diagnostics in 2022
3
Our products - low cost, accurate, non-invasive, non-lab dependent lung cancer & tuberculosis tests
4
Our CE Mark is targeted for 2023, allowing product distribution in EU countries; clear path to FDA clinical trials
5
We have a portfolio of proprietary material, filed patents and licensed IPs
6
Each year: 10 million new TB infections & 2 million deaths; 2.1 million new Lung Cancer cases & 2 million new deaths
7
Our TB test is specifically developed to meet all WHO requirements for performance, cost and use
8
British Biocell International (BBI) is our manufacturing partner
Our Team
10 M tuberculosis infections w/ 2 M deaths yearly. 130 M yearly tests are needed (WHO) 1 billion smokers globally. 15% of smokers get lung cancer. Non-smoker can get lung cancer. Millions people go untested due to lack of affordable medical technology to support large-scale testing. We can meet this need w/ our patented breakthrough technology
Show More
Pitch
Overview
Overview
Updates
What People Say
Ask a Question